List of insiders holdings for G1 Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ESHELMAN FREDRIC N Director | 2024-02-21 16:30:39 | 4,766,074 0 | 4,766,074 | Form 13D |
| Eshelman Ventures LLC 10% Owner | 2017-05-24 20:29:42 | 3,439,151 0 | 3,439,151 | Form 4 |
| MedImmune Ventures Inc. 10% Owner | 2017-12-18 17:48:05 | 2,950,630 0 | 2,950,630 | Form 4 |
| RA CAPITAL MANAGEMENT LLC RA Capital Healthcare Fund LP Kolchinsky Peter Fmr 10% Owner See Footnote (2) | 2017-05-24 16:34:27 | 0 2,684,244 | 2,684,244 | Form 4 |
| Thorp Clay Hatteras Venture Advisors IV SBIC LLC Hatteras Venture Partners IV SBIC LP INGRAM ROBERT ALEXANDER Crumpler John LEE KENNETH B JR Reed Douglas MD 10% Owner | 2021-02-12 16:16:05 | 1,756,462 0 | 1,756,462 | Form 13G |
| Bailey John E. (Jack) Jr. President and CEO | 2024-01-08 06:02:52 | 690,894 0 | 690,894 | Form 4 |
| Velleca Mark A. Director | 2023-08-10 16:11:04 | 358,286 0 | 358,286 | Form 4 |
| MOSSINGHOFF GREGORY J Chief Business Officer | 2017-05-16 21:18:34 | 320,565 0 | 320,565 | Form 3 |
| MUIR GLENN P Director | 2023-06-16 16:07:07 | 225,358 0 | 225,358 | Form 4 |
| Avagliano Mark Chief Business Officer | 2024-03-22 16:09:30 | 217,834 0 | 217,834 | Form 4 |
| MURDOCK TERRY L Chief Operating Officer | 2024-01-08 06:00:43 | 178,138 0 | 178,138 | Form 4 |
| Malik Rajesh Chief Medical Officer | 2024-02-13 18:14:36 | 169,938 0 | 169,938 | Form 4 |
| Umstead John W. V Chief Financial Officer | 2024-03-22 16:08:08 | 161,396 0 | 161,396 | Form 4 |
| Perry Andrew Chief Commercial Officer | 2024-01-08 06:03:09 | 154,152 0 | 154,152 | Form 4 |
| Strum Jay Chief Scientific Officer | 2019-01-02 17:46:25 | 144,237 0 | 144,237 | Form 4 |
| Thomas Monica R. General Counsel | 2024-03-22 16:10:31 | 115,651 0 | 115,651 | Form 4 |
| Moses Jennifer K. CFO | 2023-01-05 20:26:25 | 102,420 0 | 102,420 | Form 4 |
| SHAFFER CHRISTY L Director | 2017-12-04 17:06:30 | 0 101,503 | 101,503 | Form 4 |
| Hanson James S. General Counsel | 2023-01-05 20:25:32 | 76,787 0 | 76,787 | Form 4 |
| Gupta Soma Chief Commercial Officer | 2021-01-05 18:22:44 | 69,000 0 | 69,000 | Form 4 |
| PHILLIPS BARCLAY A SVP & Chief Financial Officer | 2019-01-02 17:29:23 | 60,000 0 | 60,000 | Form 4 |
| Flowers Cynthia Louise Director | 2023-06-16 16:07:09 | 55,889 0 | 55,889 | Form 4 |
| Nicholson Garry A Director | 2023-06-16 16:06:29 | 54,389 0 | 54,389 | Form 4 |
| Secor Alicia Director | 2023-06-16 16:06:36 | 50,000 0 | 50,000 | Form 4 |
| Deese Willie A Director | 2022-06-24 16:51:19 | 44,389 0 | 44,389 | Form 4 |
| Lee Jacks Director | 2023-06-16 16:06:53 | 40,000 0 | 40,000 | Form 4 |
| Sharpless Norman Director | 2023-06-16 16:07:22 | 40,000 0 | 40,000 | Form 4 |
| DEMAREE JOHN Chief Commercial Officer | 2020-02-07 16:15:07 | 30,000 0 | 30,000 | Form 4 |
| RUDNICK SETH Director | 2021-06-30 16:05:05 | 16,248 5266 | 21,514 | Form 4 |
| WITTY ANDREW Director | 2019-06-14 16:30:47 | 20,000 0 | 20,000 | Form 4 |
| Sullivan Timothy Eugene Director | 2017-05-19 18:59:03 | 0 0 | 0 | Form 3 |
| Rivers Tyrell Director | 2017-05-16 21:23:07 | 0 0 | 0 | Form 3 |